Adding AUS as a drug price reference country raise concerns
By Nho, Byung Chul | translator Alice Kang
22.11.14 06:00:10
가나다라
0
Health authorities move to add ‘Canada and Australia’ as a pricing reference country
Canada and Australia are known for distributing drugs at the lowest price... “use as comparator unfair”
Already oversaturated with G7 reference countries...industry calls for a ‘STOP’ in unilateral downward application of prices
The health authorities are known to be considering including Canada and Australia as reference countries for drug pricing reevaluations.
Currently, the Ministry of Health and Welfare, Health Insurance Review and Assessment Service, and the National Health Insurance Service refer to drug prices of G7 countries - US, UK, Germany, Switzerland, Italy, France, and Japan – for evaluations and assessments. Adding the two countries, which are considered to be those with the lowest drug price, is expected to raise some issues.
From what has been known so far, the government is planning to include Canada and Australia as reference countries and use the drug prices of the c
Nho, Byung Chul(sasiman@dailypharm.com)
If you want to see the full article, please JOIN US (click)